Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

6.99
BATS BZX Real-Time Price
As of 1:06pm ET
 -0.13 / -1.83%
Today’s Change
6.78
Today|||52-Week Range
19.43
-48.49%
Year-to-Date

Today’s Trading

Previous close7.12
Today’s open6.94
Day’s range6.78 - 7.44
Volume306,656
Average volume (3 months)1,076,116
Market cap$619.9M
Dividend yield--
Data as of 1:06pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-102.09%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book17.56

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.07+0.48%
NKNantKwest Inc-0.25-3.68%
PACBPacific Biosciences ...+0.43+4.72%
RLYPRelypsa Inc-0.78-4.51%
Data as of 1:06pm ET, 02/09/2016

Financials

Next reporting dateApril 22, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers